Detalhe da pesquisa
1.
Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction.
Physiology (Bethesda)
; 38(5): 0, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37013947
2.
Exogenous Galactosylceramide as Potential Treatment for CLN3 Disease.
Ann Neurol
; 86(5): 729-742, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31393621
3.
Impaired AMP-Activated Protein Kinase Signaling in Heart Failure With Preserved Ejection Fraction-Associated Atrial Fibrillation.
Circulation
; 146(1): 73-76, 2022 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35858165